Compositions and methods for the treatment of bleeding disorders
CA 1281647 C · Owner: Novo Nordisk A/S · Inventors: Hedner, Ulla Karin Elisabeth
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for treating patients suffering from bleeding disorders not caused by clotting factor defects or clotting factor inhibitors, as well as a novel composition for use in treating bleeding disorders are disclosed. The method includes administering to a patient a composition comprising an effective haemostatic amount of factor VIIa and is particularly effective in treating patients suffering from thrombocytopenia and von Willebrand's disease as well, as other platelet disorders. A composition suitable for use in treating such bleeding disorders comprises purified factor VIIa in a concentration of at least 25 µg/ml.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted March 19, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended March 19, 2008.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.